Serum tumor markers were tested at that time, with borderline CEA levels (5.4 ng/ml; upper limit of normal, 5.0 ng/ml) and significantly elevated CA19-9 levels (1,168 U/ml; upper limit of normal, 35 U/ml). The gene discussed is CEACAM5; the disease is neoplasm.